Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, Serraino D, Franceschi S, Talamini R
S.O.C. Epidemiologia e Biostatistica, IRCCS, Centro di Riferimento Oncologico, Aviano, Pordenone, Italy.
Ann Oncol. 2009 Feb;20(2):353-7. doi: 10.1093/annonc/mdn565. Epub 2008 Aug 22.
Obesity has been associated to increased hepatocellular carcinoma (HCC) risk, but studies on the topic do not fully account for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Likewise, an increased risk has been reported for diabetes mellitus (DM) but whether DM is an independent risk factor has not been established yet. To evaluate the association of obesity and DM with HCC risk, we conducted a hospital-based, case-control study in two Italian areas.
From 1999 to 2003, 185 HCC cases and 404 hospital controls were enrolled. Blood samples were obtained for HBV and HCV screening.
After allowance for known risk factors, body mass index >/=30 kg/m(2) [odds ratio (OR) = 1.9, 95% confidence interval (CI) 0.9-3.9] and DM (OR = 3.7, 95% CI 1.7-8.4) were associated to HCC risk. These associations persisted (OR = 3.5, 95% CI 1.6-7.7 for obesity; OR = 3.5, 95% CI 1.3-9.2 for DM) among subjects without HBV and/or HCV infection. Overall, 23% of HCC cases seemed attributable to these conditions, and this figure rose to 37% among subjects without HBV and/or HCV infections.
The present study provides further evidence that obesity and DM increase HCC risk and that these factors may explain a relevant proportion of cases among subjects without markers of HBV/HCV infection.
肥胖与肝细胞癌(HCC)风险增加有关,但关于该主题的研究并未充分考虑乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染情况。同样,糖尿病(DM)的风险也有所增加,但DM是否为独立风险因素尚未确定。为评估肥胖和DM与HCC风险的关联,我们在意大利的两个地区开展了一项基于医院的病例对照研究。
1999年至2003年,共纳入185例HCC病例和404例医院对照。采集血样进行HBV和HCV筛查。
在考虑已知风险因素后,体重指数≥30 kg/m²(比值比[OR]=1.9,95%置信区间[CI] 0.9 - 3.9)和DM(OR = 3.7,95% CI 1.7 - 8.4)与HCC风险相关。在无HBV和/或HCV感染的受试者中,这些关联依然存在(肥胖者OR = 3.5,95% CI 1.6 - 7.7;DM者OR = 3.5,95% CI 1.3 - 9.2)。总体而言,23%的HCC病例似乎可归因于这些情况,在无HBV和/或HCV感染的受试者中,这一比例升至37%。
本研究进一步证明肥胖和DM会增加HCC风险,且这些因素可能解释了无HBV/HCV感染标志物受试者中相当比例的病例。